BresaGen, Cythera complete merger

By Melissa Trudinger
Friday, 09 July, 2004

The merger between Bresagen's US subsidiary Bresagen Inc and San Diego stem cell company Cythera has been completed.

The Adelaide-based company's administrators said the merger was executed on 28 June 2004.

According to the merger agreement, which was announced last month, the merger of Bresagen and Cythera was to be accompanied by a US$5 million capital raising. Bresagen (ASX:BGN) will own about 30 per cent of the combined entity and have a seat on the board.

Bresagen and Cythera initially announced the deal in November last year, but in January the Australian company went in to voluntary administration after plans to spin out its Australian protein pharmaceuticals division derailed. The division has since been acquired by Queensland-based CBio in a restructuring deal.

Related News

Sleep apnoea patients who use CPAP live longer: study

CPAP therapy has been found to significantly reduce the risk of death for people with obstructive...

Does exercise really extend lifespan? It's complicated

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Nature helps to relieve physical pain

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd